Gayle Robert Dolecek
Direttore/Membro del Consiglio presso Sucampo Pharma Europe Ltd.
Profilo
Gayle Robert Dolecek is currently a Director at Sucampo Pharma Europe Ltd.
and a Professor at Parenteral Drug Association.
Previously, Gayle was a Director and SVP-Research & Development at Sucampo Pharmaceuticals, Inc. from 2006 to 2011, and a Director-Compendial Operations at the Center for Drug Evaluation & Research.
Gayle received a graduate degree from the University of Hawai'i at Hilo and undergraduate and doctorate degrees from the University of Maryland.
Posizioni attive di Gayle Robert Dolecek
Società | Posizione | Inizio |
---|---|---|
Parenteral Drug Association | Corporate Officer/Principal | - |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Direttore/Membro del Consiglio | 07/08/2008 |
Precedenti posizioni note di Gayle Robert Dolecek
Società | Posizione | Fine |
---|---|---|
Center for Drug Evaluation & Research | Corporate Officer/Principal | - |
SUCAMPO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 15/11/2011 |
Formazione di Gayle Robert Dolecek
University of Maryland | Doctorate Degree |
University of Hawai'i at Hilo | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Parenteral Drug Association | |
Center for Drug Evaluation & Research | Government |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
- Borsa valori
- Insiders
- Gayle Robert Dolecek